Exploring Under the Surface: Yielding Higher Value From Life Science Transactions
October 28, 2008
While many now acknowledge the importance of intellectual property (IP) due diligence in evaluating investments, strategic partnerships, licensing, and M&A deals, those issues that lie below the surface are often overlooked, decreasing company value and opening the door for future litigation. A due diligence plan should delve deeper, consider the full life cycle of the company, and incorporate strategies for managing IP, regulatory, and business issues.
Life science CEOs, entrepreneurs, venture capitalists, managers, and in-house counsel recently attended Exploring Under the Surface: Yielding Higher Value From Life Science Transactions. For questions or further details, please contact Zulaikha Rahim at zrahim@foley.com.
People
Related Insights
June 10, 2025
Foley Viewpoints
EPA to Approve Texas use of CO2 Sequestration Wells
Today, the EPA took an important step in allowing Texas to issue permits for Class VI wells within the state. Class VI wells are used for…
June 10, 2025
Foley Viewpoints
Supreme Court Rejects Minimum Contacts Requirement to Subject Foreign States to Suits in the U.S. Under FSIA
On June 5, 2025, in a unanimous decision authored by Justice Alito, the United States Supreme Court held that the Foreign Sovereign Immunities Act of 1976 (FSIA), 28 U.S.C. §§1330, 1602 et seq., does not require a plaintiff to prove a foreign state has made “minimum contacts” with the United States sufficient to satisfy the personal jurisdiction test set forth in International Shoe Co. v. Washington, 326 U.S. 310, 316 (1945).
June 10, 2025
Foley Ignite
Investor Insights: An Overview of PitchBook’s H1 2025 VC Tech Survey
Having done a deep dive into PitchBook’s H1 2025 VC Tech Survey, not to mention living and breathing the state of venture with my clients who are in market for capital, I wanted to share my thoughts about how investors appear to be recalibrating their approach to technology startups.